Compartir
CFR 21, Parts 300 to 499, Food and Drugs, April 01, 2017 (Volume 5 of 9) (en Inglés)
Office of the Federal Register (Cfr)
(Autor)
·
Regulations Press
· Tapa Blanda
CFR 21, Parts 300 to 499, Food and Drugs, April 01, 2017 (Volume 5 of 9) (en Inglés) - Office of the Federal Register (Cfr)
$ 1,030.26
$ 1,873.19
Ahorras: $ 842.94
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Estados Unidos
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Lunes 17 de Junio y el
Viernes 28 de Junio.
Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.
Reseña del libro "CFR 21, Parts 300 to 499, Food and Drugs, April 01, 2017 (Volume 5 of 9) (en Inglés)"
Code of Federal Regulations Title 21, Volume 5, April 1, 2017 contains regulations governing Food and Drugs and may also be referenced as: - Code of Federal Regulations Title 21, Volume 5, April 1, 2017- CFR Title 21- CFR 21, Food and Drugs- CFR 21, Parts 300 to 499, Food and DrugsThis volume contains Parts 300 to 499: - Part 300; GENERAL- Part 310; NEW DRUGS- Part 312; INVESTIGATIONAL NEW DRUG APPLICATION- Part 314; APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG- Part 315; DIAGNOSTIC RADIOPHARMACEUTICALS- Part 316; ORPHAN DRUGS- Part 317; QUALIFYING PATHOGENS- Part 320; BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS- Part 328; OVER-THE-COUNTER DRUG PRODUCTS INTENDED FOR ORAL INGESTION THAT CONTAIN ALCOHOL- Part 329; NONPRESCRIPTION HUMAN DRUG PRODUCTS SUBJECT TO SECTION 760 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT- Part 330; OVER-THE-COUNTER (OTC) HUMAN DRUGS WHICH ARE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED- Part 331; ANTACID PRODUCTS FOR OVER-THE-COUNTER (OTC) HUMAN USE- Part 332; ANTIFLATULENT PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 333; TOPICAL ANTIMICROBIAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 335; ANTIDIARRHEAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 336; ANTIEMETIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 338; NIGHTTIME SLEEP-AID DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 340; STIMULANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 341; COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 343; INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEU-MATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 344; TOPICAL OTIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 346; ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 347; SKIN PROTECTANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 348; EXTERNAL ANALGESIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 349; OPHTHALMIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 350; ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 352; SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE [STAYED INDEFINITELY]- Part 355; ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 357; MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 358; MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE- Part 361; PRESCRIPTION DRUGS FOR HUMAN USE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED: DRUGS USED IN RESEARCH- Part 369; INTERPRETATIVE STATEMENTS RE WARNINGS ON DRUGS AND DEVICES FOR OVER-THE-COUNTER SALE- Parts 370-499; Reserved
